tiprankstipranks
Ensysce Biosciences announces partnership with specialty drug manufacturer
PremiumThe FlyEnsysce Biosciences announces partnership with specialty drug manufacturer
2M ago
Ensysce Biosciences doses first subjects in PF614-MPAR trial
Premium
The Fly
Ensysce Biosciences doses first subjects in PF614-MPAR trial
2M ago
Ensysce Biosciences Reports Improved Financial Results
Premium
Company Announcements
Ensysce Biosciences Reports Improved Financial Results
2M ago
Ensysce leadership participates at Annual Pain Therapeutics Summit
PremiumThe FlyEnsysce leadership participates at Annual Pain Therapeutics Summit
3M ago
Ensysce Biosciences responds to recent shareholder inquiries
Premium
The Fly
Ensysce Biosciences responds to recent shareholder inquiries
4M ago
Ensysce Biosciences receives Nasdaq notice
Premium
The Fly
Ensysce Biosciences receives Nasdaq notice
4M ago
Ensysce Biosciences to sell 3.55M shares at 47c in registered direct offering
PremiumThe FlyEnsysce Biosciences to sell 3.55M shares at 47c in registered direct offering
5M ago
Ensysce Biosciences receives $14M NIH grant for novel opioid development
Premium
The Fly
Ensysce Biosciences receives $14M NIH grant for novel opioid development
5M ago
ENSC Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
ENSC Upcoming Earnings Report: What to Expect?
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100